948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Abagovomab: An anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
    Journal Article

    Grisham, R. N.; Berek, J.; Pfisterer, J.; Sabbatini, P.
    Immunotherapy (2011)

    Fulltext@MSK | Save
  • Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-hodgkin lymphoma
    Journal Article

    Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C. H.; Noy, A.; Straus, D.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • HER2-amplified breast cancer: Mechanisms of trastuzumab resistance and novel targeted therapies
    Journal Article

    Gajria, D.; Chandarlapaty, S.
    Expert Review of Anticancer Therapy (2011)

    Fulltext@MSK | Save
  • Temozolomide in the treatment of high-grade gliomas in children: A report from the Children's Oncology Group
    Journal Article

    Cohen, K. J.; Pollack, I. F.; Zhou, T.; Buxton, A.; Holmes, E. J.; Burger, P. C.; Brat, D. J.; Rosenblum, M. K.; Hamilton, R. L.; Lavey, R. S.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Central nervous system cancers: Clinical practice guidelines in oncology
    Journal Article

    Brem, S. S.; Bierman, P. J.; Brem, H.; Butowski, N.; Chamberlain, M. C.; Chiocca, E. A.; De Angelis, L. M.; Fenstermaker, R. A.; Friedman, A.; Gilbert, M. R.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
    Journal Article

    Bell-Mcguinn, K. M.; Matthews, C. M.; Ho, S. N.; Barve, M.; Gilbert, L.; Penson, R. T.; Lengyel, E.; Palaparthy, R.; Gilder, K.; Vassos, A.; more...
    Gynecologic Oncology (2011)

    Fulltext@MSK | Save
  • NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors
    Journal Article

    Demetri, G. D.; von Mehren, M.; Antonescu, C. R.; DeMatteo, R. P.; Ganjoo, K. N.; Maki, R. G.; Pisters, P. W. T.; Raut, C. P.; Riedel, R. F.; Schuetze, S.; more...
    Journal of the National Comprehensive Cancer Network (2010)

    Fulltext@MSK | Save
  • A phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
    Journal Article

    Younes, A.; Vose, J. M.; Zelenetz, A. D.; Smith, M. R.; Burris, H. A.; Ansell, S. M.; Klein, J.; Halpern, W.; Miceli, R.; Kumm, E.; more...
    British Journal of Cancer (2010)

    Fulltext@MSK | Save
  • Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
    Journal Article

    Wolchok, J. D.; Neyns, B.; Linette, G.; Negrier, S.; Lutzky, J.; Thomas, L.; Waterfield, W.; Schadendorf, D.; Smylie, M.; Guthrie, T. Jr; more...
    Lancet Oncology (2010)

    Fulltext@MSK | Save
  • Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: A phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
    Journal Article

    Wilson, W. H.; O'Connor, O. A.; Czuczman, M. S.; LaCasce, A. S.; Gerecitano, J. F.; Leonard, J. P.; Tulpule, A.; Dunleavy, K.; Xiong, H.; Chiu, Y. L.; more...
    Lancet Oncology (2010)

    Fulltext@MSK | Save